We Manufacture Products That Change Lives™

Life changing perinatal tissue allografts based on our proprietary BioREtain® process.

ABOUT US

Best-In-Class Perinatal Tissue Allografts

  • BioStem Technologies® produces innovative perinatal tissue-based allografts.
  • Our membrane allografts are manufactured using our proprietary BioREtain® processing method that preserves the quality of the tissue.
  • In our AATB® accredited, FDA® registered, cGMP compliant lab, we strive to provide products and services that adhere to Current Good Tissue Practice requirements.
ABOUT US

Best-In-Class Perinatal Tissue Allografts

  • BioStem Technologies® produces innovative perinatal tissue-based allografts.
  • Our membrane allografts are processed using our proprietary BioREtain® processing method that preserves the biologic quality of the tissue.
  • In our AATB® accredited, FDA® registered, cGMP compliant lab, we strive to provide products and services that adhere to Current Good Tissue Practice requirements.
Working with us

Why Choose Us

Who We Are

BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies.

Why BioStem

Our allografts are processed utilizing our proprietary BioREtain® method, which focuses on preserving the tissue’s endogenous biological properties while maintaining the structure and matrix found in fresh perinatal tissue.

Our Goal

BioStem is committed to improving patients’ quality of life through scientific innovation and strict adherence to our quality system.

How We Help

Latest News

Zacks Research Report: BSEM Continues to Exceed Expectations

Zacks Research Report: BSEM Continues to Exceed Expectations

11/13/2024 By Brad Sorensen, CFA OTC:BSEM READ THE FULL BSEM RESEARCH REPORT BioStem Technologies, Inc. (OTC:BSEM) is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The company states its mission is “to discover, develop and produce the most effective regenerative medicine products in the world,” and we believe that the company is well on its way…

Stay In Touch

Subscribe To Our Newsletter

To stay up to date on all of our news, products, and achievements, please subscribe to our newsletter.

Our Social Media: